Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Penelope MacRae

Advertisement
Set Alert for Articles By Penelope MacRae

Latest From Penelope MacRae

India Leads Global 65% Surge In Antibiotics Use

Human antibiotic consumption globally jumped dramatically between 2000 and 2015, with India posting the biggest rise, reports a new US study, which calls for a radical policy rethink to prevent antimicrobial drug resistance soaring.

India Policy & Regulation

Daiichi Demands Court Block Fortis Sale Until Singhs Pay $550m Arbitration Award

Daiichi Sankyo has demanded that an Indian court block a mega-deal to sell Indian hospital chain Fortis to a local healthcare provider until the hospital chain’s founders, Malvinder Singh and Shivinder Singh, pay a $550m international arbitration award to the Japanese drugmaker.
Commercial Companies

Hilleman Eyes Bangladesh Approval Of Novel, Cheaper Cholera Vaccine This Year

Indian vaccine research organization Hilleman Laboratories says it is hoping to get its "new design", cheaper cholera vaccine licensed in Bangladesh this year and that the next step will be to seek to make it available to UN agencies amid remaining global inoculation need.

Bangladesh Commercial

IIL's Combo Vaccine Wins Big Indian Tender, But Pentavalent Concerns Linger

State-owned Indian Immunologicals Ltd., one of the local companies aiming to challenge the dominance of multinationals in the domestic Indian vaccine market, has come up with a low-priced five-in-one jab for children that the government is including in its massive national immunization program.

India Vaccines

Call For India Compulsory Licenses For Last Resort TB Drugs

Public health campaigners in India and globally are pushing the government to allow Indian generic firms to make cheap copies of two new-generation, last resort antibiotics for drug-resistant tuberculosis through the use of patent-busting compulsory licenses. 

India Policy & Regulation

Zydus Partners Medicure To Launch First Branded Drug In US

Zydus Cadila is teaming up with Canada’s Medicure Inc to launch cholesterol control medication Zypitamag, its first branded drug in the key US market, as the Indian firm drives ahead with a strategy of diversifying from low-priced generics.

Commercial Strategy
See All
Advertisement
UsernamePublicRestriction

Register